NovoPath has introduced a next-generation LIS that integrates digital pathology workflows, unifying case tracking, image management, and reporting to streamline operations and reduce laboratory handoffs.
RealTime Laboratories has introduced a 31-marker urinary mycotoxin panel, adding 16 new fungal metabolites and using proprietary hydrolysis with LC-MS/MS to improve mold and toxin detection.
Siemens Healthineers has introduced the CN-3000 and CN-6000 hemostasis analyzers in the US, offering integrated testing methodologies and up to 13 hours of walkaway time for mid- and high-volume clinical laboratories.
Leica Biosystems has launched the HistoCore LIGHTNING C Laser Cassette Printer, a UV laser system that prints barcodes in as little as 2.5 seconds per cassette, aiming to streamline histology workflows and improve specimen traceability.
The rollout links more than 350 pathology experts across 12 countries to support routine case review and AI diagnostic integration.
Quest Diagnostics will integrate a 50-biomarker lab test panel into the Apple Health app, allowing US users to order preventive testing and access clinical results on iPhone and iPad.
Waters has launched the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometer with up to five lasers and 78 detectors, enabling analysis of over 50 single-cell characteristics with less than 10% variation, according to the company.
MolDX has proposed a draft Local Coverage Determination to establish Medicare coverage criteria for optical genome mapping in hematologic neoplasms, with public comment open through Oct. 11, 2026, according to Bionano Laboratories.
A Columbia University study finds that combining plasma p-tau217 blood tests with APOE4 genotyping can predict Alzheimer’s symptom onset within three to four years in high-risk, asymptomatic individuals.
Pillar Biosciences and Hamilton Company have launched an automated NGS library prep method for the oncoReveal Nexus 21 Gene Panel, validated for use on Hamilton’s Microlab STAR and STARlet liquid handling systems.
The FDA has granted Breakthrough Device Designation to Pattern Bioscience’s Urine ID/AST Panel, a same-day assay for pathogen ID and antimicrobial susceptibility directly from uncultured urine specimens.
OGT has expanded its SureSeq Universal NGS Unique Dual Index portfolio, enabling up to 384 uniquely indexed samples per run on Illumina platforms, quadrupling previous capacity and supporting higher-throughput workflows, according to the company.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The automated urinalysis system integrates chemistry and microscopy to help labs manage higher testing volumes and reduce manual reviews to under 3%, according to the company.